Literature DB >> 3619916

Folylpolyglutamates in Leishmania major.

D V Santi, P Nolan, B Shane.   

Abstract

The intracellular folates of the protozoan parasite Leishmania major have been examined. About 95% of the exogenous [3H]folate accumulated by the protozoan is metabolized to polyglutamate conjugates within 65 hr, and the intracellular folates are about forty-fold concentrated over the folate in the medium. The predominant metabolite of folic acid is the pentaglutamate conjugate (85%), with lessor amounts of the tetraglutamate (approximately 9%) and hexaglutamate (approximately 3%), and trace (less than 2.5%) amounts of di-, tri- and hepta-glutamate conjugates. Chromatographic properties of the products indicate that the conjugates are linked through the gamma-carboxyl groups. The folylpolyglutamate distribution in Leishmania is similar to that found in mammalian tissues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619916     DOI: 10.1016/0006-291x(87)90759-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Antileishmanial activities of 2,4-diaminoquinazoline putative dihydrofolate reductase inhibitors.

Authors:  J D Berman; M King; N Edwards
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 2.  Folate metabolic pathways in Leishmania.

Authors:  Tim J Vickers; Stephen M Beverley
Journal:  Essays Biochem       Date:  2011       Impact factor: 8.000

3.  PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major.

Authors:  A R Bello; B Nare; D Freedman; L Hardy; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

4.  The amplified H circle of methotrexate-resistant leishmania tarentolae contains a novel P-glycoprotein gene.

Authors:  M Ouellette; F Fase-Fowler; P Borst
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.